The current model of AD is based on the amyloid-β (Aβ) hypothesis, in which a series of deterministic events may lead from tau protein and Aβ deposition to neurodegeneration and progressive decline of cognitive function. This evidence concerns the gene MAPT and Alzheimer disease.